NovaQuest BioPharma manages product and company-related investments in the global healthcare industry. Our primary focus is product-based investments in late-stage clinical and commercial BioPharma programs. The BioPharma team has worked together since 2000 and brings over 100 years of collective deal-making experience. Our strategy and investments are customized to meet the structural, accounting, and governance needs of our partners and to provide material co-funding to the industry.
NovaQuest BioPharma invests together alongside with global BioPharma companies in their most core, highly strategically important product programs, ensuring alignment with our partners.
- Clinical and commercial program with compelling data and material NPVs
- R&D and/or SG&A co-investment to align BioPharma companies and NovaQuest interests
- Single-asset and multiple-asset NovaQuest investments
- Material but right-sized NovaQuest investment (up to $250m+)
- Flexible and customized structures to meet BioPharma companies financial and accounting needs
- BioPharma companies retain program’s strategic and operational control
- Simplified investment governance and contracting
- NovaQuest investment across all Therapeutic Areas
- NovaQuest provides Development and commercial operations expertise and services.
|Not Disclosed||Not Disclosed|
|Not Disclosed||Phase III|